Recombinant Adeno-Associated Virus Serotype 9 Leads to Preferential Cardiac Transduction In Vivo
Christina A. Pacak(University of Florida), Barry J. Byrne(University of Florida), Irene Zolotukhin(Florida College), Melissa A. Lewis(The University of Texas at Arlington), Denise E. Cloutier(Anna Needs Neuroblastoma Answers), Bijoy Thattaliyath(Anna Needs Neuroblastoma Answers), Cathryn Mah(Anna Needs Neuroblastoma Answers), Alice F. Tarantal(University of California, Davis), Thomas J. Conlon(Adelson Foundation)
Cited by 400
Related Papers
Treatment of Leber Congenital Amaurosis Due to <i>RPE65</i> Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial
|Human Gene Therapy|2008|950
Mutational Analysis of the Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Construction of AAV2 Vectors with Altered Tropism
|Journal of Virology|2000|392
Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy
|Proceedings of the National Academy of Sciences|2009|322
Human <i>RPE65</i> Gene Therapy for Leber Congenital Amaurosis: Persistence of Early Visual Improvements and Safety at 1 Year
|Human Gene Therapy|2009|312
Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors
|Proceedings of the National Academy of Sciences|1998|305